Can peptides help reduce inflammation, joint pain, and arthritis symptoms? Research suggests that some peptides, including GLP-1, BPC-157, and Thymosin Beta-4 (TB-4), may help regulate inflammation and support tissue repair. However, the evidence varies for each peptide, and more human studies are needed before they can be considered standard treatments for arthritis.

This discussion explores 3 powerful peptides for inflammation, joint pain, and arthritis—GLP-1 (Glucagon-Like Peptide-1), BPC-157 (Body Protection Compound-157), and Thymosin Beta-4 (TB-4)—including how they work, their potential benefits, and what current research says about their role in inflammatory and autoimmune conditions.

If you’re living with rheumatoid arthritis, osteoarthritis, psoriatic arthritis, ankylosing spondylitis, lupus, or chronic joint pain, understanding these emerging therapies can help you have more informed conversations with your healthcare team.

While peptide research is promising, many of these therapies are still being studied. They should not replace evidence-based medical care, and any treatment decisions should be made with a qualified healthcare professional.